# Value of Platelet-Rich Plasma in Post Severe Acute Respiratory Syndrome Coronavirus 2

> **NCT05395845** · EARLY_PHASE1 · UNKNOWN · sponsor: **Aya abdelnasser hassani** · enrollment: 88 (estimated)

## Conditions studied

- Anosmia

## Interventions

- **BIOLOGICAL:** platelets rich plasma

## Key facts

- **NCT ID:** NCT05395845
- **Lead sponsor:** Aya abdelnasser hassani
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-06-01
- **Primary completion:** 2022-12-01
- **Final completion:** 2023-01-01
- **Target enrollment:** 88 (ESTIMATED)
- **Last updated:** 2022-05-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05395845

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05395845, "Value of Platelet-Rich Plasma in Post Severe Acute Respiratory Syndrome Coronavirus 2". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05395845. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*